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See Article, pages 323–328In this issue of the Journal, Shores and colleagues
report that sexual transmission may be associated with
higher rates of spontaneous hepatitis C virus (HCV)
clearance in HIV infected patients. In an international
cross-sectional study of 769 HIV/HCV coinfected
patients (positive for HIV and HCV antibodies), HCV
RNA status was assessed at an undetermined timepoint
following initial HCV infection. Evidence of spontane-
ous HCV clearance (as determined by a single negative
HCV RNA test in the absence of any HCV-speciﬁc
treatment) was found in 13% of patients overall, a lower
rate than the 20–30% rate generally found in HCV
monoinfected populations [1]. In multivariate analysis,
the only factors predicting negative HCV RNA were
HBV coinfection and the risk factor for HIV and/or
HCV transmission. Rates of spontaneous clearance were
11.6% in those presumed to be infected through injecting
drug use (IDU) and 21.9% in those infected through sex-
ual contact. Further, although the number of patients
reporting homosexual contact as a risk factor was small,
these patients had a similar rate of negative HCV RNA
as the IDU group (13.5% vs 11.6%). Diﬀerences in spon-
taneous clearance rates appeared to be driven by the
group with heterosexual contact as the major risk factor
for viral transmission (26% of whom were HCV RNA0168-8278/$34.00  2008 European Association for the Study of the Liver.
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mission was independently associated with negative
HCV RNA with an odds ratio of 2.81 (95% CI 1.55–
5.09, p = 0.001). The authors declare that the reasons
for this are unclear but postulate that the observed dif-
ferences may be linked to smaller viral inoculums or dif-
fering genital immune responses in the group infected
through heterosexual contact. However, a more likely
explanation for their ﬁndings would appear to be diﬀer-
ential risk of re-exposure and subsequent HCV re-infec-
tion across the study groups.
HCV re-infection following spontaneous HCV clear-
ance has been demonstrated in both chimpanzees [2–7]
and humans [8–12]. In chimpanzees with clearance of
primary infection, HCV rechallenge with both homolo-
gous or heterologous virus can lead to HCV re-infec-
tion, despite the presence of persistent humoral
immunity [2–7]. There is often rapid control of viral rep-
lication, accelerated clearance of viraemia and greater
likelihood of spontaneous resolution of secondary
infection, suggestive of partial protective immunity
[4,6,7]. However, some chimpanzees rechallenged with
HCV develop viral persistence [2]. A number of studies
have now demonstrated that control of re-infection is
likely associated with HCV-speciﬁc T-cell responses
[3,5,13].
In human studies, similar ﬁndings have been
observed. HCV re-infection following spontaneous
HCV clearance has been described in children receiving
multiple transfusions for thalassemia [8] and among
IDU [10–12] and MSM [14] who were subsequently
re-exposed to the virus. One study of acute infection
and re-infection following spontaneous HCV clearancePublished by Elsevier B.V. All rights reserved.
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re-infection was at a lower level, generally transient
and of shorter duration than compared to initial infec-
tion [15]. In addition, some cohort studies suggest that
IDU with previous clearance of HCV have a lower risk
of developing de novo infection [16–19]. Moreover, in
some of these studies, individuals that had spontane-
ously cleared HCV infection and subsequently acquired
HIV infection during the follow-up period lost this appar-
ent immune protection, implicating a role for CD4+ T-
cells in HCV-speciﬁc immunity [16,18]. Despite these
ﬁndings, the true extent to which protective immunity
exists is confounded by demographic, behavioural and
genetic diﬀerences in the populations studied, and diﬃ-
culties in performing adequate interval sampling in lon-
gitudinal studies in IDUs. A further cohort study from a
young, high-risk injecting cohort from Sydney with
more frequent testing found no diﬀerence in the rate
of HCV infection in uninfected individuals as compared
to those with previously HCV clearance, suggesting lim-
ited protective immunity [20]. The level of protective
immunity following spontaneous HCV clearance may
remain a topic of debate and further research. However,
it is clear that HCV re-infection does occur and is partic-
ularly common among some population groups.
These data have relevance to the study by Shores
et al. suggesting that mode of acquisition may be associ-
ated with spontaneous HCV clearance. Whilst the
authors propose various mechanisms for their ﬁndings,
a more likely explanation may be a simpler one of risk
behaviour and re-exposure resulting in re-infection and
a higher cross-sectional prevalence of chronic HCV
infection among individuals with injecting drug use
and homosexual contact as their risk factor for HCV
acquisition. This study gives no details of the duration
from ﬁrst HCV exposure or information on risk behav-
iour patterns in the various groups. The median age of
41 years indicates that the majority of subjects, particu-
larly in the IDU group, would be many years from ini-
tial HCV exposure. Further, the cross-sectional study
design means that spontaneous HCV clearance rates
are in fact rates of negative viraemia at a single time
point. High levels of ongoing risk behaviour in IDU,
after spontaneous [16,18] and even treatment-induced
HCV clearance [21,22], are well documented. Thus,
repeated exposures to HCV, particularly with diﬀerent
genotypes, may have resulted in establishment of
chronic HCV infection in many IDU subjects who ini-
tially cleared primary HCV infection. Primary sexual
transmission of HCV via the heterosexual route on the
other hand is relatively uncommon even in the setting
of longstanding discordant relationships [23], thus sub-
sequent re-infection may be less likely, even in the set-
ting of ongoing re-exposure.
The ﬁnding that the rate of negative HCV viraemia in
those with homosexual contact was lower than ratesobserved in heterosexually acquired infection is intrigu-
ing. In recent years, a signiﬁcant increase in sexually
acquired acute HCV infection among HIV positive men
whohave sexwithmen (MSM)has beenobserved inmany
countries [24–29]. A case control study performed in Lon-
don demonstrated that acquisition in this setting was
associated with a particular set of high-risk behaviours
including group sex, use of non parenteral recreational
(‘party’) drugs, traumatic sexual practices and the co-exis-
tence of other sexually transmitted infections [28]. Re-
infection following spontaneous clearance of sexually
acquiredHCV in anHIV positiveMSMhas recently been
described [12] and there is further preliminary data to sug-
gest that rates of re-infection in this setting may be high
[14], presumably due to repeated exposures and lack of
modiﬁcation of ongoing high-risk behaviours. Again,
no further details on risk factor behaviour in the homo-
sexual group were provided in the study by Shores et al.
[30] so any conclusions must be speculative, but the per-
ceived ‘low rate of spontaneous clearance’ in the homo-
sexually acquired cases may in fact represent instead a
high rate of HCV re-exposure through ongoing high-risk
sexual behaviour, similar to that observed in IDUs.
In summary, the true rate of spontaneous viral clear-
ance after primary HCV infection cannot be adequately
determined through a cross-sectional study performed at
an indeterminate time following initial infection. Whilst
the rate of clearance in subjects with low or absent ongo-
ing risk behaviour may be relatively accurate (the esti-
mated rate of clearance of 25% in the heterosexually
infected group was consistent with that of other
reported studies [1]), the rate of spontaneous clearance
may be falsely estimated in groups with ongoing high-
risk behaviour due to recurrent HCV re-exposure. Re-
infection incidence, and the contribution of any degree
of protective immunity, can only be truly assessed in
well-designed longitudinal prospective cohorts of high-
risk individuals. The collection of appropriate virologi-
cal, immunological and behavioural data in such studies
will not only contribute signiﬁcantly to future under-
standing of this complex area but also help inform cru-
cial public health messages.
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